tiprankstipranks
Akero Therapeutics Inc (AKRO)
NASDAQ:AKRO

Akero Therapeutics (AKRO) Ownership - Who Owns Akero Therapeutics?

440 Followers

Akero Therapeutics (AKRO) Ownership Overview

31.86%29.52%12.69%25.94%
31.86% Insiders
12.69% Other Institutional Investors
25.94% Public Companies and
Individual Investors
The ownership structure of Akero Therapeutics (AKRO) stock is a mix of institutional, retail and individual investors. Approximately 42.21% of the company’s stock is owned by Institutional Investors, 31.86% is owned by Insiders and 25.94% is owned by Public Companies and Individual Investors.
The ownership structure of Akero Therapeutics (AKRO) stock is a mix of institutional, retail and individual investors. Approximately 42.21% of the company’s stock is owned by Institutional Investors, 31.86% is owned by Insiders and 25.94% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 13, 2024
xxxxxxxxxxxxx
$53883
Jun 13, 2024
xxxxxxxxxxxxx
$63958
Jun 13, 2024
Andrew Cheng
President & Ceo,director
xxxxxxxxxxxxx
$178720
Jun 13, 2024
xxxxxxxxxxxxx
$56962

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2024
xxxxxxxxxxxxx
$344672
Mar 31, 2024
xxxxxxxxxxxxx
$3244419
Mar 31, 2024
xxxxxxxxxxxxx
$35047517
Mar 31, 2024
xxxxxxxxxxxxx
$68535558

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,461,387Institution5.01%95,880,420
3,186,084Institution4.61%88,254,527
2,999,580Institution4.34%83,088,366
2,898,417Institution4.19%80,286,151
2,713,205Institution3.92%75,155,779
2,000,526Institution2.89%55,414,570
1,543,035Institution2.23%42,742,070
1,387,471Institution2.01%38,432,947
1,326,532Institution1.92%36,744,936
1,140,000Institution1.65%31,578,000

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,186,084Institution4.61%88,254,527
2,898,417Institution4.19%80,286,151
2,000,526Institution2.89%55,414,570
1,543,035Institution2.23%42,742,070
1,140,000Institution1.65%31,578,000
713,580Institution1.03%19,766,166
673,758Institution0.97%18,663,097
568,758Institution0.82%15,754,597
521,876Institution0.75%14,455,965
503,173Institution0.73%13,937,892

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,724,852Institution2.49%47,347,187
1,940,804Institution2.81%36,525,931
1,236,682Institution1.79%31,757,994
1,004,243Institution1.45%18,899,853
524,170Institution0.76%14,388,467
421,376Institution0.61%11,566,771
326,451Institution0.47%8,383,262
231,207Institution0.33%4,351,316
174,832Institution0.25%3,290,338
102,355Institution0.15%2,809,645

FAQ

Who Owns Akero Therapeutics Inc (AKRO)?
According to the latest TipRanks data, approximately 12.69% of the company's stock is held by institutional investors, 31.86% is held by insiders, and 25.94% is held by retail investors.
    What percentage of Akero Therapeutics Inc (AKRO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 12.69% of Akero Therapeutics Inc (AKRO) stock is held by institutional investors.
      What percentage of Akero Therapeutics Inc (AKRO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 25.94% of Akero Therapeutics Inc (AKRO) stock is held by retail investors.
        Who owns the most shares of Akero Therapeutics Inc (AKRO)?
        Vanguard owns the most shares of Akero Therapeutics Inc (AKRO).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis